Lotus Ventures Inc. (CSE:J, FRA:LV9, OTC:LTTSF) (the “Company” or “Lotus”) would like to provide an update to its shareholders and prospective investors. As the Company has continued to ramp up to full production over the past month, our operational team has successfully populated 6/6 of the production rooms with plants at various stages. Lotus has its first scheduled harvest for the end of September 2019 and will be harvesting two and a half batches per month yielding 165,000 grams once at full capacity.

Favourable Initial Health Canada Facility Inspection:


During the ramp-up period, Health Canada made an initial inspection and has confirmed that our operation is compliant under the Cannabis Act and its Regulations.

B2B Sales to Commence:

As per the definitive agreement between Lotus and Auxly Cannabis Group Inc. (“Auxly”) dated September 11, 2018, Auxly has committed to purchase 50% of the initial facility’s production at a fixed cost, which is expected to be enough to cover the Company’s production costs. The remaining 50% of production will be initially sold to either a Licence Holder with a Processing licence, or to Auxly based on wholesale prices sourced by Lotus.

Facility Expansion:

The Lotus management has taken an experienced and conservative approach when planning its future expansion. Our team’s focus is to act in the best interest of our shareholders, and the Company continues to seek non-dilutive financing, including bank debt and/or other methods. Our management team has a corporate banking background and believes it can obtain non-dilutive financing moving forward.

The expansion facility is in for building permits and will be up to an additional 30,000 square feet including an in-house processing lab. Using an automated growing technique, Lotus estimates its production to be increased by approximately 4,000,000 grams of cannabis flower per year.

Financial Projections:

Lotus designed its operation under the premise that it can grow high-quality cannabis at a low-cost due to the customization of its facility, automated production systems, and the personal care given to each individual plant by its operational team. The Company estimates its production costs to be below $1.50 per gram (once at full capacity) and has continued to keep its operating expenses low with the goal to be cash flow positive in the calendar year of 2020.

ON BEHALF OF THE BOARD
Lotus Ventures Inc.
“Dale McClanaghan”
Dale McClanaghan, President and CEO

About Lotus Ventures Inc.
Lotus Ventures Inc. (CSE: J) is an Okanagan-based licensed producer focused on growing exceptional cannabis products for the B2B and future recreational market in Canada. Lotus operates an innovative 22,500 square foot growing facility with access to unique proven strains and an entirely handcrafted production process created by one of the regions most experienced growing teams.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Click here to connect with Lotus Ventures Inc (CSE:J) for an Investor Presentation.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Source: www.newswire.ca

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less

Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), one of the UK’s leading CBD and hemp product suppliers, announces that Charles Lamb will be stepping down as a Non-Executive Independent Director of the Company, with effect from April 16, 2021, to focus on his other business interests

Charles has been an integral part of the Board’s efforts to grow the Company since its inception and has played a key role in the Company’s shift in strategy to focus on growing the Love Hemp brand globally.

Keep reading... Show less

Expects to file its 2020 Annual Financial Statements on or before May 31, 2021

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) today announced that, as a result of the COVID-19 Pandemic measures, it will not be in a position to file its audited annual financial statements, the related management’s discussion and analysis and related CEO and CFO certificates (the “Annual Filings”) before the required deadline of April 30, 2021 (the “Specified Requirements”).

Keep reading... Show less

Recreational cannabis remains illegal in all Australia’s states and territories with the exception of the Australian Capital Territory (ACT). But could that change in the future?

So far there are no clear indicators as to when or if Australia could legalise recreational cannabis, but attitudes seem to be changing. Public support is growing, and there’s even some political acceptance.

Read on to learn more about when Australia may legalise recreational cannabis.

Keep reading... Show less